Print this page

Plant Graz; Austria


Key Data

Fresenius Kabi Austria in Graz offers expertise in aseptic production, a diverse portfolio of high-end products, a wide variety of container options with flexible production configurations, and a comprehensive service package from first feasibility studies to commercial manufacturing.

  1. Manufacturing Competences: 

    • aseptic and oxygen controlled processing

    • processing of highly active substances

    • compounding of complex aqueous solutions, fat emulsions and suspensions

    • lyophilization

    • purification technologies such as filtration and distillation

    • optimized terminal sterilization for temperature-sensitive products

    • pilot plant for clinical trials, pilot batches and up-scaling

  2. Primary Packaging:

    • glass vials and bottles from 2 ml to 1000 ml

    • ampoules from 1 ml to 20 ml

    • bags, flexible non PVC, single and multi-chamber from 50 ml up to 4000 ml

    • glass and plastic pre-filled syringes from 1 ml to 50 ml

  3. Product Groups:

    • infusion solutions such as anesthetics, analgesics and antibiotics (non beta-lactams) 

    • parenteral nutrition products

    • medical devices and diagnostic products, such as irrigation solutions, X-ray contrast agents

  4. Furthermore:

    • excellent audit track record and FDA approval

    • GMP, ISO 9001 and ISO 14001 certification

    • one face to the customer philosophy

    • expert support from idea to commercial production, from the first feasibility studies to commercial manufacturing


 

 

In the Spotlight

Graz has a special position within the Fresenius Kabi network as a center of competence for aseptic production of liquid pharmaceuticals. Aseptic filling at the Graz plant started almost 25 years ago, reflecting our track record of expertise and experience. The plant meets top quality standards as well as a high level of automation, but also has the flexibility to deal with very specific customer demands. The plant has undergone several significant upgrades and expansions in recent years.

 

In 2011 a project for further expansion of production capabilities and capacities combining innovative spearhead technologies with established core competences in one location was launched in Graz. This project extended Fresenius Kabi’s technology portfolio by offering new combinations of e.g. liposomal formulations and lyophilization, emulsions including highly-active pharmaceutical agents, suspensions and highly viscous and water-free formulations.

 

 

The new technologies were implemented step-by-step over 4 years without production downtime. With the investment in two new state-of-the-art aseptic filling lines for large and small volumes parenterals the production site in Graz increased total capacities for aseptic manufacturing while expanding its competences. In Graz our ambition is always to be on top of the latest developments, in order to handle complex products and processes in a reliable way. With the addition of all the new production technologies into our portfolio, we at Fresenius Kabi in Graz aim to strengthen our position as a high-end manufacturing site in the heart of Europe.